Doxylamine pyridoxine, marketed under brand names like Diclegis and Bonjesta, is a prescription medication used to treat nausea and vomiting during pregnancy. It is a combination of doxylamine succinate, an antihistamine, and pyridoxine hydrochloride, a form of vitamin B6 [1].
Why is Doxylamine Pyridoxine Prescribed for Pregnant Individuals?
This medication is specifically indicated for pregnant individuals experiencing nausea and vomiting, commonly known as morning sickness. It works by addressing the symptoms of this condition, aiming to provide relief for those affected.
How Does Doxylamine Pyridoxine Work?
Doxylamine succinate is an antihistamine that can cause drowsiness, which helps to alleviate nausea. Pyridoxine hydrochloride is a vitamin that plays a role in metabolic processes and is believed to help reduce nausea as well [1]. The combination targets the mechanisms contributing to pregnancy-related nausea and vomiting.
When Was Doxylamine Pyridoxine First Approved?
The U.S. Food and Drug Administration (FDA) first approved a formulation of doxylamine succinate and pyridoxine hydrochloride for use in pregnant individuals in 1977 under the brand name Bendectin. However, Bendectin was voluntarily withdrawn from the market in 1983 due to concerns and litigation, though extensive studies did not establish a link between the drug and birth defects. A new formulation, Diclegis, was approved in 2013, and a delayed-release version, Bonjesta, was approved in 2018 [1][2].
What are the Potential Side Effects of Doxylamine Pyridoxine?
Common side effects associated with doxylamine pyridoxine include drowsiness and dizziness. Other potential side effects can include dry mouth, urinary retention, and blurred vision. Individuals should discuss any concerns about side effects with their healthcare provider [1].
Are There Alternatives to Doxylamine Pyridoxine for Morning Sickness?
For mild nausea and vomiting, lifestyle adjustments such as eating smaller, more frequent meals, avoiding trigger foods, and staying hydrated may be sufficient. In some cases, other medications might be considered, but doxylamine pyridoxine is often a first-line prescription treatment. Consulting a healthcare provider is essential to determine the most appropriate course of action for managing pregnancy-related nausea and vomiting [3].
What is the Patent Status of Doxylamine Pyridoxine Formulations?
Patents for pharmaceutical products, including formulations like Diclegis and Bonjesta, are crucial for market exclusivity. DrugPatentWatch.com provides information on drug patents, which can indicate the duration of market protection and potential for generic competition. Information regarding the specific patents and their expiry dates for doxylamine pyridoxine formulations can be found through specialized patent databases [4].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/drug/diclegis
[3] https://www.drugpatentwatch.com/drug/bonjesta
[4] https://www.drugpatentwatch.com/